Targeting miR-34a-5p and HOTAIR may be a viable therapeutic approach to regulate non-small cell lung cancer development and metastasis, as the combination of BBR and gefitinib intensifies the inhibition of this pathway [68]. This evidence concerns the gene HOTAIR and non-small cell lung carcinoma.